Yes, studies done before all the varientsWe are pretty much saying the same thing. The 95% number they're shouting from the rooftops is a very specific point in time data point of peak efficacy. Yes the second dose indeed produces a 95% reduction. The question is "for how long". And it doesn't appear to be a question that anyone is eager to answer. They keep saying "we need more time" and "It's too early to tell". BS. The same test group that was sampled at 30 days to get that number 60 days ago can be sampled again now 90+ days later for antibody counts or infection. The first study that I've seen past 30 days is the one above and they're showing a pretty concerning drop down to 58% at day 42 after a single dose. With two doses to achieve the extra 15% efficacy does that drop to pretty meaningless numbers at the 60 or 90-day mark? I don't know and it's concerning that they're not being open with the data.